A publication titled "ACE Inhibitor-Induced Isolated Visceral Angioedema: A Diagnostic Pitfall Mimicking Inflammatory Bowel Disease" was released on October 2, 2026. The article appears in the Journal of Investigational Allergology & Clinical Immunology. Bradykinin, the compound referenced in this publication, remains classified as unapproved for research use. The publication is indexed under PubMed ID 42825307. No results, data, or conclusions from the publication have been provided beyond its title and journal placement. This brief does not summarize or interpret the content of the study. Readers interested in the specific clinical details, methodology, or findings should consult the original publication directly through the listed source. For additional background on bradykinin as a compound, readers can refer to the compound overview page.
Publication Examines ACE Inhibitor-Induced Visceral Angioedema Linked to Bradykinin
See the full bradykinin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42825307/